ArticleNature chemistry2026
Catalytic asymmetric sulfonimidoyl transfer to access chiral sulfonimidoyl fluorides and related derivatives.
Article in Nature chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Enantioselective synthesis of sulfondiimidoyl fluoridesChemical science · 2026Article
- Iron-Catalyzed Asymmetric NHAngewandte Chemie (International ed. in English) · 2026Article
- Counteranion-mediated dynamic kinetic asymmetric fluorination to access sulfur-stereogenic center.Nature communications · 2026Article
- High-Fidelity Transfer of Chiral Sulfonimidoyl Radicals.Journal of the American Chemical Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Sulfur fluoride exchange (SuFEx) click chemistry is a powerful tool for constructing functional molecules. However, catalytic asymmetric methods for constructing chiral sulfur(VI)-centred sulfonimidoyl fluorides are rare, resulting in the limited application of SuFEx. Owing to the crowded three-dimensional environment, chiral sulfonimidoyl transfer is challenging. Here we show a catalytic enantioselective Cl-F exchange reaction to realize the asymmetric sulfonimidoyl transfer reaction with racemic sulfonimidoyl chlorides as reactants, constructing chiral SuFEx connecting arms. This strategy enables chiral sulfonimidoyl azides, sulfonimidamides and sulfonimidoyl esters by reacting with corresponding nucleophiles. Mechanistic studies revealed that the reaction is a dynamic kinetic asymmetric transformation process, and a two-catalyst-bound pentacoordinate sulfur is responsible for the sulfur-configurational epimerization. The key steps involve the formation of O-sulfonimidoyl ester pyridinium cation intermediates via covalent organocatalysis. The resulting optically active sulfonimidoyl fluorides enable a further stereospecific SuFEx with C-, N- and O-centred nucleophiles, thereby establishing a modular platform for the asymmetric SuFEx ligation.
Identifiers
41721016What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.